文献速递头颈部肿瘤放疗放疗物理与技术

基于深度学习的剂量预测用于头颈部放疗计划自动化个体化质量保证

Deep Learning-Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiation Therapy Plans.
PubMed 文献 · Pract Radiat Oncol · 2023-01-24

本研究利用深度学习剂量预测评估头颈部计划质量并识别次优计划,训练3D Dense Dilated U-Net在90例计划上交叉验证,在22例测试计划上评估性能,并用14例临床计划比较预测与临床OAR剂量指标,以2 Gy或3%剂量体积阈值标记次优OAR,并与3名头颈放疗医生的手动标记比较。预测剂量分布与基于知识的计划质量相当,模型标记63个OAR,包含医生标记47个中的30个。

要点

  • 深度学习可预测高质量剂量分布,用作头颈部计划质量自动个体化评估的比较剂量分布。
  • 预测与基于知识计划靶区D1%、D95%、D99%差异分别在-2.53%±1.34%、-0.42%±1.27%、-0.12%±1.97%内。
  • 医生间标记变异性高,83%的医生标记OAR仅被3名医生中1名标记。

核心结论

  • 深度学习可预测高质量剂量分布,可用作自动、个体化评估头颈部计划质量的比较剂量分布。

研究设计与样本

  • 使用RapidPlan基于知识计划创建245例头颈部容积旋转调谐放疗计划,在头颈放疗医生监督下选取112例高质量计划。
  • 训练3D Dense Dilated U-Net架构,在90例计划上采用3折交叉验证预测三维剂量分布,模型输入包括CT图像、靶区处方以及靶区和危及器官轮廓。
  • 在其余22例测试计划上评估模型性能,并在14例临床计划上测试剂量预测模型用于计划质量自动审查。

主要发现

  • 预测剂量分布质量与基于知识计划相当,靶区D1%、D95%、D99%的预测与基于知识计划差异分别为-2.53%±1.34%、-0.42%±1.27%、-0.12%±1.97%。
  • 危及器官平均剂量和最大剂量差异分别为-0.33±1.40 Gy和-0.96±2.08 Gy。
  • 计划质量评估研究中,放疗医生标记47个可能需改进的危及器官,医生间变异性高,83%的医生标记危及器官仅被3名医生中1名标记。
  • 比较剂量预测模型标记63个危及器官,包括医生标记47个中的30个。

关键数值与推荐

  • 使用2 Gy剂量差异或3%剂量体积阈值标记正常组织保护欠佳的危及器官。
  • 预测与临床危及器官剂量指标比较用于标记次优正常组织保护。
  • 模型标记的危及器官与3名头颈放疗医生的手动标记进行比较。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to use deep learning-based dose prediction to assess head and neck (HN) plan quality and identify suboptimal plans. METHODS AND MATERIALS: A total of 245 volumetric modulated arc therapy HN plans were created using RapidPlan knowledge-based planning (KBP). A subset of 112 high-quality plans was selected under the supervision of an HN radiation oncologist. We trained a 3D Dense Dilated U-Net architecture to predict 3-dimensional dose distributions using 3-fold cross-validation on 90 plans. Model inputs included computed tomography images, target prescriptions, and contours for targets and organs at risk (OARs). The model's performance was assessed on the remaining 22 test plans. We then tested the application of the dose prediction model for automated review of plan quality. Dose distributions were predicted on 14 clinical plans. The predicted versus clinical OAR dose metrics were compared to flag OARs with suboptimal normal tissue sparing using a 2 Gy dose difference or 3% dose-volume threshold. OAR flags were compared with manual flags by 3 HN radiation oncologists. RESULTS: The predicted dose distributions were of comparable quality to the KBP plans. The differences between the predicted and KBP-planned D1%,D95%, and D99% across the targets were within -2.53% ± 1.34%, -0.42% ± 1.27%, and -0.12% ± 1.97%, respectively, and the OAR mean and maximum doses were within -0.33 ± 1.40 Gy and -0.96 ± 2.08 Gy, respectively. For the plan quality assessment study, radiation oncologists flagged 47 OARs for possible plan improvement. There was high interphysician variability; 83% of physician-flagged OARs were flagged by only one of 3 physicians. The comparative dose prediction model flagged 63 OARs, including 30 of 47 physician-flagged OARs. CONCLUSIONS: Deep learning can predict high-quality dose distributions, which can be used as comparative dose distributions for automated, individualized assessment of HN plan quality.

来源:Pract Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Gronberg MP, Beadle BM, Garden AS, et al. Deep Learning-Based Dose Prediction for Automated, Individualized Quality Assurance of Head and Neck Radiation Therapy Plans. Pract Radiat Oncol. 2023. PMID: 36697347. doi:10.1016/j.prro.2022.12.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。